Innovex CEO sells 18,837 shares at $28.50

Innovex International, Inc. Chief Executive Officer and director Adam Anderson reported an open-market sale of common stock.

Rhea-AI Filing Summary

Innovex International, Inc. Chief Executive Officer and director Adam Anderson reported an open-market sale of common stock. On February 24, 2026, he sold 18,837 shares of Innovex common stock at $28.50 per share in a transaction classified as a sale in the open market or a private transaction.

The filing states that all shares in this trade were sold at the reported price and that the sales were made pursuant to a pre-established Rule 10b5-1 trading plan adopted on March 14, 2025. After this transaction, Anderson’s directly held Innovex common stock position is 466,744 shares.

Insider Trade Summary

Net Seller: 18,837 shares

Net Sell 1 txn

Insider Anderson Adam

Role Chief Executive Officer

Sold 18,837 shs ($537K)

Type	Security	Shares	Price	Value
Sale	Common Stock	18,837	$28.50	$537K

Holdings After Transaction: Common Stock — 466,744 shares (Direct)

Footnotes (2)

1. F1. Sales pursuant to a Rule 10b5-1 plan adopted on March 14, 2025.
2. F2. All shares were sold at the price in column 4.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Innovex (INVX) CEO Adam Anderson report in this Form 4?

Adam Anderson reported an open-market sale of Innovex common stock. He sold 18,837 shares on February 24, 2026 at $28.50 per share, leaving him with 466,744 shares of directly owned Innovex common stock after the transaction.

How many Innovex (INVX) shares did the CEO sell and at what price?

The CEO sold 18,837 shares of Innovex common stock. According to the filing, all shares in this transaction were sold at a price of $28.50 per share, as reflected in the price column and confirmed by the accompanying footnote disclosure.

Does the Innovex (INVX) CEO still hold shares after this reported sale?

Yes. Following the reported sale, Adam Anderson directly holds 466,744 shares of Innovex common stock. This post-transaction ownership figure is disclosed in the Form 4 and represents his remaining direct equity stake after the February 24, 2026 sale.

Was the Innovex (INVX) CEO’s stock sale under a Rule 10b5-1 plan?

Yes. The filing specifies that the sales were made under a Rule 10b5-1 trading plan adopted on March 14, 2025. Such plans pre-schedule trades, helping executives systematically sell shares over time according to predetermined instructions.

What type of transaction did the Innovex (INVX) Form 4 disclose?

The Form 4 disclosed a non-derivative transaction in Innovex common stock. It is coded as “S,” indicating a sale in the open market or a private transaction, with 18,837 shares sold at $28.50 each on February 24, 2026.

Is the Innovex (INVX) CEO’s ownership direct or indirect after this transaction?

The filing shows that Adam Anderson’s reported Innovex holdings after the sale, totaling 466,744 shares, are held with direct ownership. The ownership code is listed as “D,” signifying direct ownership rather than indirect control through another entity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/25/2026 - 07:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Anderson Adam

(Last) (First) (Middle)

C/O INNOVEX INTERNATIONAL, INC.

19120 KENSWICK DRIVE

(Street)

HUMBLE TX 77338

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Innovex International, Inc. [ INVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/24/2026		S		18,837(1)	D	$28.5(2)	466,744	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Sales pursuant to a Rule 10b5-1 plan adopted on March 14, 2025.

2. All shares were sold at the price in column 4.

	/s/ Matt Steinheider, Attorney-in-Fact for Adam Anderson	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.